Outsourcing
Technology Improvements Drive Capacity Gains for Biologics Fill/Finish
In-house biologics fill/finish operations have invested in new technologies and have available capacity while small-molecule fill-finish facilities work at near capacity on legacy equipment.
More ...
Baxter BioPharma Solutions Joins PBOA
Nelson Patterson has been elected to Pharma & Biopharma Outsourcing Association board.
More ...
Advertisement:
PharmSource STRATEGIC ADVANTAGE - Expert global sourcing intelligence in an instant
If you procure, manage or sell contract drug development and manufacturing services, you need the industry’s most respected outsourcing information web portal. It puts hard-to-find information at your fingertips, including the strategic tools you need to make the right decisions.
Visit  www.pharmsource.com/strategic to learn more about PharmSource STRATEGIC ADVANTAGE.
Regulatory Developments
EMA Launches Drug Safety Assessment Platform
The agency creates an electronic central repository to facilitate drug safety assessment reports.
More ...
The Quest Continues for Quality Metrics
FDA aims to collect data regularly from manufacturers that will indicate the ability of a firm and its facilities to produce high-quality therapies on a continual, error-free basis.
More ...
Advertisement:
Developing a Comprehensive Tool Kit for Microbial Identification
On Demand
 Click hereTo Register Free.
API Synthesis & Manufacturing
More Growth Expected for API Custom Manufacturing in 2015
Custom API manufacturers that offer specialized capabilities will benefit from the continuing trend toward pharmaceutical outsourcing.
More ...
Advertisement:
Enhancing Quality and Process Efficiency using Continuous Manufacturing Technology for Drug Substance and Drug Product
On Demand
 Click hereTo Register Free.
Manufacturing Developments
Extending Shelf Life through Better Blister Package Designs
Better barrier materials and software modeling streamline the blister-package design process.
More ...
New Excipient Options for Oral Solid Dosage Drugs
Experts review considerations for selecting excipients for solid-dosage drug performance and manufacturability.
More ...
| 
